Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Dirk Laurent

Dirk Laurent publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Colorectal Cancer Treatments and Studies, Angiogenesis and VEGF in Cancer and Cancer Treatment and Pharmacology.

OpenAlex
World rank
#703,566
of 7,710,434 ranked researchers
Rank in Germany
#34,701
of 364,343
Works
91
Citations
8.5k
Citations per work
93.2
h-index
30
i10-index 52Top 11% in Oncology
Dirk Laurent

What does Dirk Laurent research?

Dirk Laurent's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (26%).

Health Sciences: 48 works · 52.6% of their workMedicine: 48 works · 52.6% of their workOncology: 27 works · 29.7% of their workPulmonary and Respiratory Medicine: 12 works · 13.5% of their workGastroenterology: 5 works · 5.3% of their workPathology and Forensic Medicine: 4 works · 4.1% of their workLife Sciences: 24 works · 26.4% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 26.4% of their workMolecular Biology: 13 works · 14.7% of their workCancer Research: 11 works · 11.7% of their workEverything else: 19 works · 21.0% of their workTHEIR WORKDirk Laurent91works
Life Sciences26%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4852.6%
    1. Biochemistry, Genetics and Molecular Biology2426.4%
  3. Everything else1921.0%
  1. 1Oncology30% of their works
  2. 2Molecular Biology15% of their works
  3. 3Pulmonary and Respiratory Medicine14% of their works
  4. 4Cancer Research12% of their works
  5. 5Gastroenterology5% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Dirk Laurent's research?

The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, Chemotherapy-Induced Peripheral Neuropathy, endothelial progenitor cells, Taxanes, VEGF and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Chemotherapy482 topics
  2. Cetuximab381 topic
  3. KRAS Mutations381 topic
  4. Chemotherapy-Induced Peripheral Neuropathy241 topic
  5. Taxanes241 topic
  6. VEGF241 topic
  7. endothelial progenitor cells241 topic
  8. EGFR Mutations141 topic
  9. Fatty Acid Synthase141 topic
  10. Lipid Metabolism141 topic
  11. Targeted Therapy141 topic
  12. Imatinib Mesylate111 topic
  13. Sunitinib111 topic
  14. Endoscopic Resection101 topic
  15. Gastric Cancer101 topic
  16. HIF-191 topic
  17. Warburg Effect91 topic

Where does Dirk Laurent work?

Dirk Laurent's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Dirk Laurent have?

OpenAlex counts 91 works and 8,478 citations for Dirk Laurent, an h-index of 30, ranking #703,566 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dirk Laurent. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.